Status:
COMPLETED
Vaginal, Oral and Systemic Inflammation in Preterm Birth
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Local or Systemic Signs for Infection, Preterm Birth
Eligibility:
FEMALE
18+ years
Brief Summary
The prevalence of preterm birth is not decreasing in the last decades despite of improving health care. Intrauterine infections are important in the etiology of preterm birth but the interconnection o...
Detailed Description
Vaginal, oral and systemic inflammation in preterm birth 1. Summary The prevalence of preterm birth (PTB) is increasing. While intrauterine infections may be the primary cause of PTB, remote infe...
Eligibility Criteria
Inclusion
- Pregnancy
- Written informed consent
Exclusion
- Matching with control patients not possible
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01142752
Start Date
November 1 2011
End Date
May 1 2015
Last Update
August 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Women's Hospital
Bern, Switzerland, 3010